257 related articles for article (PubMed ID: 26823024)
1. Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
BJU Int; 2017 Jan; 119(1):57-66. PubMed ID: 26823024
[TBL] [Abstract][Full Text] [Related]
2. Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.
Wu CJ; Zhang YD; Bao ML; Li H; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2017 Nov; 209(5):1081-1087. PubMed ID: 28834443
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
6. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
[TBL] [Abstract][Full Text] [Related]
7. Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6.
Song W; Bang SH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Kim CK; Lee HM
Clin Genitourin Cancer; 2018 Aug; 16(4):281-287. PubMed ID: 29550198
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer.
Kim CK; Park SY; Park JJ; Park BK
AJR Am J Roentgenol; 2014 Mar; 202(3):W270-6. PubMed ID: 24555624
[TBL] [Abstract][Full Text] [Related]
9. Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer.
Wu X; Reinikainen P; Vanhanen A; Kapanen M; Vierikko T; Ryymin P; Hyödynmaa S; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2017 Jan; 98(1):63-71. PubMed ID: 27687831
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
[TBL] [Abstract][Full Text] [Related]
12. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
[TBL] [Abstract][Full Text] [Related]
14. Utility of diffusion-weighted imaging in association with pathologic upgrading in biopsy-proven grade I endometrial cancer.
Park JJ; Kim CK; Cho SW; Kim JH
J Magn Reson Imaging; 2020 Jan; 51(1):117-123. PubMed ID: 31206949
[TBL] [Abstract][Full Text] [Related]
15. Elevated fatty acid synthase expression in prostate needle biopsy cores predicts upgraded Gleason score in radical prostatectomy specimens.
Hamada S; Horiguchi A; Kuroda K; Ito K; Asano T; Miyai K; Iwaya K
Prostate; 2014 Jan; 74(1):90-6. PubMed ID: 24108439
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
17. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
Zhang Z; Xu H; Xue Y; Li J; Ye Q
J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
[TBL] [Abstract][Full Text] [Related]
18. The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.
Nougaret S; Robertson N; Golia Pernicka J; Molinari N; Hötker AM; Ehdaie B; Sala E; Hricak H; Vargas HA
Abdom Radiol (NY); 2017 Jul; 42(7):1968-1974. PubMed ID: 28258355
[TBL] [Abstract][Full Text] [Related]
19. Predictors of pathological upgrading in low-risk prostate cancer patients without hypointense lesions on an apparent diffusion coefficient map of multiparametric magnetic resonance imaging.
Kang M; Song B; Lee I; Lee SE; Byun SS; Hong SK
World J Urol; 2016 Nov; 34(11):1541-1546. PubMed ID: 27074937
[TBL] [Abstract][Full Text] [Related]
20. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
